AI-generated · cited to primary sources · not investment advice · How we research
UTI AMC
Our verdict on UTI AMC isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.
See the verdict — free →Does management do what it says?
As of June 30, 2025, the company has established a significant presence in B30 cities with 205 out of its 255 total branches located in these areas. (2 met, 1 exceeded across 3 tracked commitments)
“We continue to have a strong hold in B30 cities vis-à-vis industry and to strengthen our presence further, we opened 68 new UTI Financial Centres across the length and breadth of the country.”
The company successfully announced the first close of SDOF IV in October 2025. (1 met across 1 tracked commitment)
“We do plan to, however, launch at least one fund in the SIF category during this current year.”
See the full cited Management analysis of UTI AMC
How durable is the business?
The Pension Fund segment is expanding rapidly, with AUM reaching ₹ 3.6 lakh crore and profit after tax growing 5% YoY. It also gained additional schemes from Max Life Pension Fund. (5 expanding across 1 engine)
“UTI PFL Q4 FY26 39 Q4 FY25 35 YoY (%) 11%”
The Alternatives segment grew its service revenue by 25% YoY, reaching ₹5 crore, as it expands its private capital and credit offerings. (1 expanding across 1 engine)
“UTI Alternatives Q4 FY26 8 Q4 FY25 4 YoY (%) 100%”
See the full cited Business Model analysis of UTI AMC
Where does growth come from?
The Alternatives business is showing accelerating growth in service fees, jumping 67% YoY for the quarter and 43% for the half-year, indicating strong traction in private capital management. (1 accelerating across 1 signal, 1 leading indicator)
“UTI Alternatives... Q4 FY26 8... Q4 FY25 4... 100% YoY”
Passive investment products (ETFs and Index funds) are showing accelerating growth, with quarterly average AUM rising 23% year-on-year, significantly outpacing the growth of traditional equity funds. (5 accelerating across 5 signals, 1 leading indicator)
“Index and ETFs... 24.86% YoY... 176,673... Mar'26”
See the full cited Future Growth analysis of UTI AMC
What could break the thesis?
The risk is easing as core profitability is growing significantly faster than total expenses. For FY25, Core PAT rose 43% YoY while total expenses only rose 7% YoY. Employee benefit expenses were well-contained, rising only 4% for the full year. (2 easing, 2 intensifying, 1 high-severity)
“Total Expenses 419 [cr] 222 [cr] 89%... Employee Benefit Expense 553 [cr] 458 [cr] 21%”
The risk is intensifying. Market share of Total MF QAAUM has continued to slide from 5.37% in March 2024 to 5.04% in March 2025. Equity market share also dropped from 3.68% to 3.10% in the same period. (3 intensifying, 1 high-severity)
“I was actually a little surprised that your equity net flows both on quarterly and yearly has been kind of negative.”
See the full cited Risk analysis of UTI AMC
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.